Crossmark

Effective bolus dose of remimazolam for i-gel® insertion in nonparalyzed patients: a dose-finding study

Published Online: 2024-04-26

Published Print: 2024-09

Authors

Cho, Eunah

Roh, Yun Ho

Moon, Jisu

Kim, Yangjin

Shin, Seokyung https://orcid.org/0000-0002-2641-0070
Funding

Funding for this research was provided by:

Hana Pharm Co., Ltd.
License Information

Text and Data Mining valid from 2024-04-26

Version of Record valid from 2024-04-26
More Information

Article History

Received: 5 July 2023

Revised: 19 February 2024

Accepted: 2 March 2024

First Online: 26 April 2024

Document is current